- Home
- / Shinshin Pharmaceutical UTICAL
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Shinshin Pharmaceutical UTICAL financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩5.7 K
2024-10-29
Market Capitalization
₩86 B
2024-10-29
Revenue
₩113.8 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 63.7B | 67.9B | 67.1B | 74.0B | 91.9B | 102.6B | 106.4B | 113.8B |
| Cost of goods sold | 32.7B | 33.1B | 36.6B | 40.7B | 46.9B | 66.1B | 66.9B | 67.5B |
| Gross profit | 31.2B | 35.0B | 31.0B | 34.1B | 45.4B | 36.8B | 39.9B | 47.0B |
| Gross profit margin, % | 49.0% | 51.5% | 46.2% | 46.0% | 49.4% | 35.9% | 37.5% | 41.3% |
| Operating expense total | 26.8B | 31.4B | 32.2B | 30.9B | 35.7B | 26.5B | 28.4B | 31.3B |
| Depreciation and amortization | 1.1B | 1.3B | 2.5B | 3.8B | 3.9B | 3.9B | 4.3B | 4.2B |
| EBITDA | 4.4B | 3.6B | (1.2B) | 3.2B | 9.7B | 10.3B | 11.5B | 15.7B |
| EBITDA margin, % | 7.0% | 5.3% | -1.9% | 4.3% | 10.5% | 10.0% | 10.8% | 13.8% |
| EBIT | 3.3B | 2.2B | (3.8B) | (1.0B) | 5.2B | 5.9B | 7.0B | 11.4B |
| EBIT margin, % | 5.1% | 3.3% | -5.6% | -1.4% | 5.7% | 5.7% | 6.6% | 10.0% |
| Interest income | 164.4M | 51.1M | 15.2M | 2.0M | 8.3M | 40.3M | 37.8M | 31.0M |
| Interest expense | 206.2M | 247.6M | 893.6M | 963.2M | 1.5B | 1.9B | 2.0B | 1.6B |
| Pre tax profit | 3.4B | 2.1B | (269.3M) | (1.7B) | 4.0B | 4.0B | 5.1B | 9.8B |
| Income tax expense | 553.1M | 106.8M | (470.6M) | (297.7M) | (308.1M) | (651.6M) | 329.1M | 526.4M |
| Net Income | 2.8B | 2.0B | 201.3M | (1.4B) | 4.4B | 4.6B | 4.8B | 9.3B |